RESUMO
INTRODUCTION: Glyphosate is a broad-spectrum non-selective herbicide, used to eliminate unwanted weeds in agricultural and forest settings. Herbicide action is achieved through inhibition of aromatic amino acid biosynthesis in plant cells. Since this is not a conserved mechanism between human and plant cells, glyphosate is considered to be a low health risk substance for humans. However, the occurrence of possible harmful side effects of glyphosate use is not well documented and controversial. Toxicity and genotoxicity studies indicate that glyphosate is not harmful, although several investigations suggest that it can alter various cellular processes in animals. Therfore this has potential as a health and environmental risk factor in areas where glyphosate is widely used. OBJECTIVES: The present study evaluated glyphosate cytotoxic and genotoxic effects in normal human cells (GM38) and human fibrosarcoma (HT1080) cells. MATERIALS AND METHODS: Acute and chronic cytotoxicity were determined through the exposure of cultured cells to graded concentrations of glyphosate, and cell viability analysis was performed with crystal violet and Trypan blue staining. Genotoxicity was determined using the comet assay and data significance was evaluated with Dunnet's test. RESULTS: For chronic cytotoxicity a dose-dependent effect was observed in both GM38 and HT1080 cells after treatment with 5.2-8.5 mM and 0.9-3.0 mM glyphosate, respectively. In the acute cytotoxicity study, GM38 cells exposed to 4.0-7.0 mM glyphosate and HT1080 cells exposed to 4.5-5.8 mM glyphosate, had cell viability counts higher than 80%. Genotoxic effects were evidenced in GM38 cells at glyphosate concentrations of 4.0-6.5 mM and in HT1080 cells at glyphosate concentrations of 4.75 -5.75 mM. CONCLUSIONS: The levels of cytotoxicity and genotoxicity of glyphosate occurring in mammalian cells suggested that its mechanism of action is not limited to plant cells.
Assuntos
Inibidores Enzimáticos/toxicidade , Glicina/análogos & derivados , Herbicidas/toxicidade , Linhagem Celular , Sobrevivência Celular , Ensaio Cometa , Glicina/toxicidade , Humanos , Testes de Mutagenicidade , Estatística como Assunto , GlifosatoRESUMO
El cáncer gástrico es la principal causa de mortalidad por cáncer en Colombia. El riesgo de desarrollar cáncer gástrico se ha asociado con factores ambientales y con la infección por Helicobacter pylori. Las enzimas glutatión-S-transferasas están involucradas en la Desintoxicación de varios carcinógenos ambientales. Las deleciones homocigóticas de glutatión-S-transferasa M1 (GSTM1-0) y glutatión-S-transferasa T1 (GSTT1-0) se han asociado con algunos tipos de cáncer. Los niveles del factor de necrosis tumoral (FNT alfa ) están aumentados en pacientes infectados por H. pylori. Una transición G/A en la posición -308 del promotor del FNT-alfa se ha visto relacionada en algunos estudios con un incremento en la expresión del gen, y está asociada con la susceptibilidad a cáncer gástrico. Se investigó la asociación de estos polimorfismos con cáncer gástrico y la interacción con otros factores de riesgo (estilo de vida). Se obtuvieron muestras de sangre de 46 pacientes con cáncer gástrico y 96 controles. Se empleó el modelo de regresión logística para obtener la razón de posibilidades (OR) y sus intervalos de confianza del 95% y, así, establecer la asociación entre los polimorfismos enzimáticos y el cáncer gástrico, y entre otros factores independientes y esta enfermedad. Las frecuencias de los polimorfismos de deleción en pacientes y controles fueron: para la GSTM1, 65,2% y 37,5%, y para la GSTT1, 17,4% y 14,6%, respectivamente. La frecuencia del polimorfismo G/A del FNT alfa en las personas infectadas con H. pylori fue de 18% en la población con cáncer gástrico y de 7% en el grupo control. Nuestros resultados sugieren que el polimorfismo de deleción de GSTM1 puede estar asociado con un riesgo aumentado de cáncer gástrico (OR 5,5; IC95%, 1,7-17,2). Igualmente, nuestros datos muestran que otros factores de riesgo como la infección por H. pylori y el consumo de cigarrillo y alcohol están asociados con este tipo de cáncer (OR 5,58; IC95% 1,81-17,19; OR 6,70; IC95%, 2,20-20,30 y OR 3,27; IC95% 1,14-9,4, respectivamente).
Gastric cancer (GC) is the main cause of mortality by cancer in Colombia. Glutathione Stransferase (GST) enzymes are involved in the detoxification of many environmental carcinogens. The homozygous deletions of glutathione S-transferase M1 (GSTM1-0) and glutathione Stransferase T1 (GSTT1-0) have been associated with several types of cancer. The risk to develop GC has been associated with environmental factors and Helicobacter pylori infection. The tumor necrosis factor (TNF-alpha ) and its levels are increased in patients infected with H. pylori. A G/A transition in the position -308 of the promoter of the TNF-alpha has been related in several studies to an increased expression of the gene and is associated with susceptibility to GC. The association of these polymorphisms with GC and the interaction with other risk factors (life style) were investigated. Blood samples were obtained from 46 GC patients and 96 controls. The logistic regression model was used to obtain the odds ratio (OR) and their 95% confidence intervals. These statistics established the association between the enzymatic polymorphisms and GC and between other independent factors and GC. The frequency of the TNF-alpha polymorphism in people infected with H. pylori was 18% in the GC population and 7% in the control group. This transition was not significantly associated with H. pylori infection and GC. The frequencies of the deletion polymorphisms for patients and controls were as follows: GSTM1 65.2% and 37.5%; GSTT1 17.4% and 14.6%. These results suggested that the GSTM1 deletion polymorphism was associated with an increased risk of gastric cancer (OR of 5.5; 95%CI, 1.7-17.2). Furthermore, other risk factors such as H. pylori infection (OR 5.58,CI 1.8-17.2), smoking (OR 6.70, CI 2.2-20.3) and alcohol intake (OR 3.27, CI 1.1-9.4) were associated with GC.
